115972 ⎘
Transferases transferring phosphorus-containing groups (2.7); Nucleotidyltransferases (2.7.7) RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
Method of preparing cell free nucleic acid molecules by in situ amplification
#302Immunogenic Compositions
#303Telomerase encoding DNA vaccine
#304Sample preparation methods, systems and compositions
#305TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION
#306Stabilized reverse transcriptase fusion proteins
#307Chimeric antigen receptor cell preparation and uses thereof
#308Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#309STABILIZED REVERSE TRANSCRIPTASE FUSION PROTEINS
#310PEPTIDE HAVING NEURONAL LOSS PREVENTION AND REGENERATION EFFECTS, AND COMPOSITION CONTAINING SAME
#311MMLV REVERSE TRANSCRIPTASE VARIANTS
#312Production of nucleic acid
#313Cancer vaccine for cats
#314Electrochemical impedimetric biosensing microchip for real time telomerase activity detection
#315COMPOSITIONS FOR INCREASING POLYPEPTIDE STABILITY AND ACTIVITY, AND RELATED METHODS
#316Methods and compositions for preventing concatemerization during template-switching
#317PEPTIDE HAVING FIBROSIS INHIBITORY ACTIVITY AND COMPOSITION CONTAINING SAME
#318Methods of cell renewal
#319METHODS FOR TAGGING AND AMPLIFYING RNA TEMPLATE MOLECULES FOR PREPARING SEQUENCING LIBRARIES
#320DYNAMIC GENOME ENGINEERING
#321Mutant polymerases and uses thereof
#322Multipotent Adult Stem Cells and Methods for Isolation
#323Mutant reverse transcriptase
#324Methods and compositions for preventing concatemerization during template-switching
#325Peptide for preventing hearing loss, and composition comprising same
#326Modified Antibody
#327Oligonucleotide compositions and methods of making the same
#328Oligonucleotide compositions and methods of making the same
#329DNA polymerases with improved activity
#330DNA POLYMERASES WITH IMPROVED ACTIVITY
#331NOVEL REVERSE TRANSCRIPTASES FOR USE IN HIGH TEMPERATURE NUCLEIC ACID SYNTHESIS
#332Detection of particle-contained reverse transcriptase activity
#333Universal cancer peptides derived from telomerase
#334Anti-Inflammatory Peptides and Composition Comprising the Same
#335Methods and reagents for reverse-transcription polymerase chain reaction
#336Production of nucleic acid
#337USE OF RNASE H FOR THE SELECTIVE AMPLIFICATION OF VIRAL DNA
#338DIRECT CRISPR SPACER ACQUISITION FROM RNA BY A REVERSE-TRANSCRIPTASE-CAS1 FUSION PROTEIN
#339Anti-Inflammatory Peptides and Composition Comprising the Same
#340Telomerase polypeptide vaccine for treating cancer
#341Telomerase polypeptide vaccine for treating cancer
#342Telomerase reverse transcriptase-based therapies
#343GENOMICALLY-ENCODED MEMORY IN LIVE CELLS
#344Engineered cells for adoptive cell therapy
#345TERT fusions
#346Methods for adding adapters to nucleic acids and compositions for practicing the same
#347Methods for adding adapters to nucleic acids and compositions for practicing the same
#348Nucleic acid modifying enzymes
#349Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction
#350DNA polymerases with improved activity
#351Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof
#352Anti-inflammatory peptides and composition comprising the same
#353IMPROVED NGS WORKFLOW
#354Modified oligonucleotides for telomerase inhibition
#355PLANT PLASTID TRANSFORMATION METHOD
#356Anti-inflammatory peptides and composition comprising the same
#357Composition for organ, tissue, or cell transplantation, kit, and transplantation method
#358Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#359cDNA SYNTHESIS USING A REVERSIBLY INACTIVATED REVERSE TRANSCRIPTASE
#360LYOPHILIZED REAGENT, MIXED REAGENT SOLUTION, AND METHOD FOR STORING LYOPHILIZED REAGENT
#361DNA polymerases with improved activity
#362Peptide having fibrosis inhibitory activity and composition containing same
#363Reverse transcriptase mixtures with improved storage stability
#364Mutant Reverse Transcriptase and Methods of Use
#365PEPTIDES DERIVED FROM GSE 24.2 FOR TREATING DISEASES CAUSED BY OXIDATIVE STRESS AND DAMAGE TO DNA
#366Conditionally replicating adenovirus
#367COMPOSITIONS AND METHODS FOR PROVIDING ACTIVE TELOMERASE TO CELLS IN VIVO
#368Peptide having angiogenesis inhibitory activity and composition containing same
#369Stabilized reverse transcriptase fusion proteins
#370REVERSIBLY INACTIVATED THERMOSTABLE REVERSE TRANSCRIPTASES, COMPOSITIONS AND METHODS FOR USE
#371Telomerase encoding DNA vaccine
#372Method for Eliciting an Immune Response to Human Telomerase Reverse Transcriptase
#373Method for cancer detection, diagnosis and prognosis
#374Compositions for increasing polypeptide stability and activity, and related methods
#375NEW METHODS TO PRODUCE ACTIVE TERT
#376Composition for treating and preventing benign prostatic hyperplasia
#377NGS WORKFLOW
#378Methods of making chimeric antigen receptor-expressing cells
#379RECOMBINANT REVERSE TRANSCRIPTASES
#380Cell-penetrating peptide and conjugate comprising same
#381DNA polymerases
#382Method of modulating sex hormone levels using a sex hormone secretion modulator
#383HIV type 1 group O reverse transcriptases that are active at high temperatures
#384Composition and methods for treating ischemic damage
#385Cancer vaccine for cats
#386Cancer vaccine for dogs
#387Modified antibody
#388HIV-1 integrase derived peptides and compositions
#389DNA POLYMERASES AND RELATED METHODS
#390COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#391Composition for preventing or treating sepsis
#392DNA polymerases with improved activity
#393Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
#394Modified oligonucleotides for telomerase inhibition
#395ADIPOSE-DERIVED STEM CELLS AND LATTICES
#396Multipotent adult stem cells and methods for isolation
#397Composition for preventing or treating cachexia
#398Oligonucleotide compositions and methods of making the same
#399Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#400Modified oligonucleotides for telomerase inhibition
#401Modified oligonucleotides for telomerase inhibition
#402Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#403DNA polymerases with improved activity
#404Universal cancer peptides derived from telomerase
#405Pluripotent cells derived from bone marrow and methods for isolation
#406Method for preparing specific cells of human-derived cells
#407Methods and compositions for treating cancer
#408Reverse transcriptases for use in high temperature nucleic acid synthesis
#409Composition for preventing or treating rheumatoid arthritis
#410Anti-Inflammatory Peptides and Composition Comprising the Same
#411Methods for adding adapters to nucleic acids and compositions for practicing the same
#412Reverse transcriptase with enhanced properties
#413Thermostable reverse transcriptases and uses thereof
#414Linker-bridged gene or domain fusion reverse transcriptase enzyme
#415DNA polymerases with improved activity
#416Compounds, compositions, methods, and kits relating to telomere extension
#417Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment
#418Production of nucleic acid
#419Targeted 2′-O-methylation of telomerase non-coding RNA
#420DNA polymerases with improved activity
#421Variant reverse transcriptase
#422Telomerase polypeptide vaccine for treating cancer
#423Method for transfecting nucleic acid to cell and nucleic acid complex
#424Telomerase activity inhibiting peptide and manufacturing method and application thereof
#425Modified oligonucleotides for telomerase inhibition
#426MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#427DNA polymerases with improved activity
#428ADIPOSE-DERIVED STEM CELLS AND LATTICES
#429Modified antibody
#430Production of nucleic acid
#431MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#432Reverse transcriptase mixtures with improved storage stability
#433Use of interfering rna for treating an hiv infection
#434Thermostable reverse transcriptases and uses thereof
#435Stabilized reverse transcriptase fusion proteins
#436Plant plastid transformation method
#437Human telomerase catalytic subunit
#438DNA POLYMERASES AND RELATED METHODS
#439TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
#440HIV-1 integrase derived stimulatory peptides interfering with integrase—Rev protein binding
#441MAMMALIAN RNA DEPENDENT RNA POLYMERASE
#442Nucleic acid modifying enzymes
#443COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#444cDNA SYNTHESIS USING A REVERSIBLY INACTIVATED REVERSE TRANSCRIPTASE
#445Compositions for increasing polypeptide stability and activity, and related methods
#446Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#447Production of nucleic acid
#448Method for cancer detection, diagnosis and prognosis
#449Adipose-derived stem cells and lattices
#450ALLOSTERIC TRANS-SPLICING GROUP I RIBOZYME WHOSE ACTIVITY OF TARGET-SPECIFIC RNA REPLACEMENT IS CONTROLLED BY THEOPHYLLINE
#451Telomerase reverse transcriptase variant
#452Recombinant reverse transcriptases
#453RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#454Combined telomerase inhibitor and gemcitabine for the treatment of cancer
#455Cancer treatment by combined inhibition of proteasome and telomerase activities
#456MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#457Compositions and methods for temperature-dependent nucleic acid synthesis
#458Kit for detection of telomerase reverse transcriptase nucleic acids
#459Multipotent adult stem cells and methods for isolation
#460Multipotent adult stem cells and methods for isolation
#461Retrotransposon Inhibition in Therapy
#462Multipotent adult stem cells and methods for isolation
#463RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#464CNS-tumor treatment method and composition
#465RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#466RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#467RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#468RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#469RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
#470Modulation of line-1 reverse transcriptase
#471Telomerase RNA Subunit and Methods of Use Thereof
#472Modulation of line-1 reverse transcriptase
#473Method for eliciting an immune response to human telomerase reverse transcriptase
#474Mutant reverse transcriptase and methods of use
#475RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#476Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
#477COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#478Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
#479Polycationic compositions for cellular delivery of polynucleotides
#480RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#481Cloned Genes Encoding Reverse Transcriptase lacking RNase H Activity
#482Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same
#483Modulation of telomere length by oligonucleotides having a G-core sequence
#484Regulatory segments of the human gene for telomerase reverse transcriptase
#485RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
#486Thermostable reverse transcriptases and uses thereof
#487Telomerase-inhibiting ENA oligonucleotide
#488Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)
#489METHOD FOR INHIBITING TELOMERASE ACTIVITY
#490Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use
#491Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
#492Antiviral oligonucleotides having a conserved G4 core sequence
#493Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#494Viral polymerase and modulation thereof
#495Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#496Protocol for optimizing purification of enzymatically active human telomerase
#497RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)
#498Antibody to telomerase reverse transcriptive
#499Multipotent adult stem cells
#500Cloned genes encoding reverse transcriptase lacking RNase H activity
#501Novel gene having reverse transcriptas motif
#502RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
#503RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
#504RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
#505Cloned genes encoding reverse transcriptase lacking RNase H activity
#506Recombinant reverse transcriptases
#507Aptamer constructs
#508Polycationic compositions for cellular delivery of polynucleotides
#509RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#510RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
#511Methods and compositions for blocking progression of a disease state
#512RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)
#513RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
#514RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
#515RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)
#516Multipotent adult stem cells and methods for isolation
#517RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)
#518RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)
#519RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)
#520RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
#521RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)
#522RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)
#523RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
#524RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)
#525RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
#526RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)
#527RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
#528RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)
#529RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)
#530RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)
#531RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
#532RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)
#533RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#534RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
#535RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)
#536RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
#537RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)
#538RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)
#539RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
#540Modified oligonucleotides for telomerase inhibition
#541Modulation of line-1 reverse transcriptase
#542Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
#543Producing telomerase activators and inhibitors by screening with purified telomerase
#544RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
#545Adipose-derived stem cells and lattices
#546RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
#547Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
#548RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
#549Treating cancer using an oligonucleotide N3′->N5′ thiophosphoramidate
#550RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
#551Vaccine containing the catalytic subunit of telomerase for treating cancer
#552Telomerase interference
#553Telomerase interference
#554Reverse transcriptase variants
#555Composition for regulating production of proteins
#556Reverse transcriptase variants
#557RNase inhibitors
#558Methods of treating or preventing age related disorders
#559Mutant reverse transcriptase